Profound Medical Corp.
General ticker "PROF" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $177.8M (TTM average)
Profound Medical Corp. follows the US Stock Market performance with the rate: 39.6%.
Estimated limits based on current volatility of 1.9%: low 6.49$, high 6.74$
Factors to consider:
- Total employees count: 87 as of 2024
- US accounted for 60.5% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Limited operating history, Capital intensity, Market acceptance, Reimbursement risks, Partner dependency
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [5.09$, 11.18$]
- 2026-12-31 to 2027-12-31 estimated range: [4.63$, 10.35$]
Financial Metrics affecting the PROF estimates:
- Negative: with PPE of -5.3 at the end of fiscal year the price was high
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Shareholder equity ratio, % of 85.75 > 64.29
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of -0.11 > -0.60
- Positive: Industry inventory ratio change (median), % of -0.30 <= -0.16
Short-term PROF quotes
Long-term PROF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $7.20MM | $10.68MM | $16.10MM |
| Operating Expenses | $35.85MM | $43.74MM | $57.35MM |
| Operating Income | $-28.65MM | $-33.06MM | $-41.25MM |
| Non-Operating Income | $0.20MM | $5.24MM | $-1.06MM |
| R&D Expense | $14.42MM | $16.96MM | $20.60MM |
| Income(Loss) | $-28.45MM | $-27.82MM | $-42.32MM |
| Taxes | $-0.13MM | $-0.00MM | $0.25MM |
| Net Income(Loss)* | $-28.57MM | $-27.82MM | $-43.32MM |
| Stockholders Equity | $31.22MM | $60.42MM | $66.43MM |
| Inventory | $6.99MM | $5.80MM | $11.28MM |
| Assets | $43.96MM | $70.23MM | $77.47MM |
| Operating Cash Flow | $-22.61MM | $-23.45MM | $-38.21MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.25MM |
| Investing Cash Flow | $0.00MM | $0.00MM | $-0.24MM |
| Financing Cash Flow | $1.76MM | $54.70MM | $41.14MM |
| Earnings Per Share** | $-1.35 | $-1.12 | $-1.43 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.